Product Description
Fusidic Acid is a bacteriostatic antibiotic derived from the fungus Fusidium coccineum and used as a topical medication to treat skin infections. Fusidic acid acts as a bacterial protein synthesis inhibitor by preventing the turnover of elongation factor G (EF-G) from the ribosome. Fusidic acid is effective primarily on gram-positive bacteria.
Mechanisms of Action: Protein Synthesis Inhibitor, CAT Inhibitor
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Topical, Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Algeria | Argentina | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Arrevus
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: United States
Active Clinical Trial Count: 2
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Conjunctivitis, Bacterial|Impetigo
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT06911424 |
BXP-301 | P3 |
Recruiting |
Conjunctivitis, Bacterial |
2025-12-15 |
10% |
2025-05-20 |
Primary Endpoints|Start Date|Treatments|Trial Status |
2020-002219-24 |
IMPET | P3 |
Completed |
Impetigo |
2023-04-20 |
2025-06-30 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
11/20/2025 |
News Article |
Topical Antibiotic Drug Market Size to Capture USD 9.59 Billion by 2034 |
|
09/26/2023 |
News Article |
Fusidic Acid Market 2023 Report Revealing the Latest Trends and Outlook for Advancements by 2030 |
|
09/25/2023 |
News Article |
Distributed Acoustic Sensors (DAS) Market 2023 Size Share and Growth 2023-2030 |
|
09/21/2023 |
News Article |
Windshield Washer Fluids Market 2023 Size Share and Growth 2023-2030 |